The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.

The expression of many genes involved in xenobiotic/drug metabolism and transport is regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR). These receptors establish crosstalk with other nuclear receptors or transcription factors controlling signaling pathways that regulate the homeostasis of bile acids, lipids, glucose, inflammation, vitamins, hormones, and others. These crosstalks are expected to modify profoundly our vision of xenobiotic/drug disposition and toxicity. They provide molecular mechanisms to explain how physiopathological stimuli affect xenobiotic/drug disposition, and how xenobiotics/drugs may affect physiological functions and generate toxic responses. In addition, the possibility that xenosensors may control other signaling pathways opens the way to new pharmacological opportunities.

[1]  L. Moore,et al.  Functional and structural comparison of PXR and CAR. , 2003, Biochimica et biophysica acta.

[2]  S. Surapureddi,et al.  Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Fukamizu,et al.  Hepatocyte Nuclear Factor-4 Is a Novel Downstream Target of Insulin via FKHR as a Signal-regulated Transcriptional Inhibitor* , 2003, The Journal of Biological Chemistry.

[4]  B. Goodwin,et al.  The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. , 1999, Molecular pharmacology.

[5]  E. Ben-Chetrit,et al.  Colchicine: 1998 update. , 1998, Seminars in arthritis and rheumatism.

[6]  B. Goodwin,et al.  Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. , 2002, Molecular pharmacology.

[7]  Sean Ekins,et al.  A Ligand-Based Approach to Understanding Selectivity of Nuclear Hormone Receptors PXR, CAR, FXR, LXRα, and LXRβ , 2002, Pharmaceutical Research.

[8]  M. Stoffel,et al.  Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Kliewer Pregnane X receptor: predicting and preventing drug interactions. , 2005, Thrombosis research.

[10]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[11]  P. Watkins,et al.  Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. , 2006, The Journal of clinical investigation.

[12]  J. Kraniak,et al.  Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. , 1998, Molecular Pharmacology.

[13]  P. Watkins,et al.  Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. , 1997, Molecular pharmacology.

[14]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[15]  Matthew D Krasowski,et al.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts. , 2005, Molecular endocrinology.

[16]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[17]  D. Greenblatt,et al.  Effects of the Antifungal Agents on Oxidative Drug Metabolism , 2000, Clinical pharmacokinetics.

[18]  C. Carlberg,et al.  Identification of pregnane X receptor binding sites in the regulatory regions of genes involved in bile acid homeostasis. , 2005, Journal of molecular biology.

[19]  J. Pascussi,et al.  Expression of CYP3A4, CYP2B6, andCYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes* , 2002, The Journal of Biological Chemistry.

[20]  E. Sotaniemi,et al.  Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency. , 1989, Diabetes research.

[21]  S. Matern,et al.  Stimulation of bile acid 6α-hydroxylation by rifampin , 1996 .

[22]  L. Poellinger,et al.  Role of CYP3A4 in the regulation of the aryl hydrocarbon receptor by omeprazole sulphide. , 2006, Cellular signalling.

[23]  T. Sueyoshi,et al.  Drug-activated nuclear receptors CAR and PXR , 2003, Annals of medicine.

[24]  T. Sueyoshi,et al.  The Nuclear Orphan Receptor CAR-Retinoid X Receptor Heterodimer Activates the Phenobarbital-Responsive Enhancer Module of the CYP2B Gene , 1998, Molecular and Cellular Biology.

[25]  C. Handschin,et al.  Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans. , 2001, Molecular endocrinology.

[26]  M. Negishi,et al.  CAR and PXR: The xenobiotic-sensing receptors , 2007, Steroids.

[27]  P. Meier,et al.  Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. , 1999, Gastroenterology.

[28]  O. Hankinson Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. , 2005, Archives of biochemistry and biophysics.

[29]  Wissem Mnif,et al.  Estrogens and antiestrogens activate hPXR. , 2007, Toxicology letters.

[30]  G. Williams,et al.  Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. , 2002, The Journal of endocrinology.

[31]  D. Moore,et al.  Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. , 2005, Endocrinology.

[32]  Y. Liu,et al.  Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[33]  T. Efferth,et al.  Role of glucose-6-phosphate dehydrogenase for oxidative stress and apoptosis , 2006, Cell Death and Differentiation.

[34]  J. Sumpter,et al.  Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. , 2000, The Journal of biological chemistry.

[35]  C. Koike,et al.  Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes , 2004, Molecular and Cellular Biology.

[36]  A. Kong,et al.  Induction of phase I, II and III drug metabolism/transport by xenobiotics , 2005, Archives of pharmacal research.

[37]  D. Reinberg,et al.  Transcription. Switching partners in a regulatory tango. , 2001, Science.

[38]  Jerry Donovan,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. , 2003, Nature.

[39]  Alvaro Puga,et al.  Ah receptor signals cross-talk with multiple developmental pathways. , 2005, Biochemical pharmacology.

[40]  P. Maurel,et al.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.

[41]  Vincent Laudet,et al.  Principles for modulation of the nuclear receptor superfamily , 2004, Nature Reviews Drug Discovery.

[42]  J. Pascussi,et al.  Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. , 2003, Molecular pharmacology.

[43]  Paul T Tarr,et al.  Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.

[44]  Christoph Handschin,et al.  Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.

[45]  David Carling,et al.  The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.

[46]  R. Pollenz,et al.  Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. , 1999, Molecular pharmacology.

[47]  J. Macías,et al.  Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients , 2003, HIV clinical trials.

[48]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[49]  J. Pascussi,et al.  Ketoconazole and Miconazole Are Antagonists of the Human Glucocorticoid Receptor: Consequences on the Expression and Function of the Constitutive Androstane Receptor and the Pregnane X Receptor , 2006, Molecular Pharmacology.

[50]  J. Chiang,et al.  Bile acid regulation of gene expression: roles of nuclear hormone receptors. , 2002, Endocrine reviews.

[51]  C. Tohyama,et al.  Modulation of oestrogen receptor signalling by association with the activated dioxin receptor , 2003, Nature.

[52]  Y. Gu,et al.  Cross-talk between the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor Signaling Pathways , 1999, The Journal of Biological Chemistry.

[53]  M. Kamiński,et al.  Influence of cholesterol and protein diet on liver cytochrome P-450-dependent monooxygenase system in rats. , 1996, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[54]  J. Thomsen,et al.  The Orphan Nuclear Receptor SHP Inhibits Agonist-dependent Transcriptional Activity of Estrogen Receptors ERα and ERβ* , 1999, The Journal of Biological Chemistry.

[55]  H. Adami,et al.  RAPID HEALING OF DUODENAL ULCERS WITH OMEPRAZOLE: DOUBLE-BLIND DOSE-COMPARATIVE TRIAL , 1983, The Lancet.

[56]  K. Wikvall,et al.  6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes , 1999 .

[57]  C. Handschin,et al.  Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.

[58]  C. Glass,et al.  Nuclear Integration of Glucocorticoid Receptor and Nuclear Factor-κB Signaling by CREB-binding Protein and Steroid Receptor Coactivator-1* , 1998, The Journal of Biological Chemistry.

[59]  K. Wikvall,et al.  Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α,7α,12α-triol in human liver microsomes , 1999 .

[60]  D. Hardie,et al.  AMP-activated Protein Kinase Mediates Phenobarbital Induction of CYP2B Gene Expression in Hepatocytes and a Newly Derived Human Hepatoma Cell Line* , 2005, Journal of Biological Chemistry.

[61]  W. L. Nelson,et al.  Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced Osteomalacia , 2006, Molecular Pharmacology.

[62]  C. Mattingly,et al.  Estrogen Receptor Reduces CYP1A1 Induction in Cultured Human Endometrial Cells* , 1999, The Journal of Biological Chemistry.

[63]  U. Meyer,et al.  In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase , 2007, Proceedings of the National Academy of Sciences.

[64]  D. Kelly,et al.  PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. , 2006, The Journal of clinical investigation.

[65]  A. Walsh,et al.  Dietary Cholesterol Fails to Stimulate the Human Cholesterol 7α-Hydroxylase Gene (CYP7A1) in Transgenic Mice* 210 , 2002, The Journal of Biological Chemistry.

[66]  R Ohlsson,et al.  Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Evans,et al.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[69]  K. Bock Aryl hydrocarbon or dioxin receptor: biologic and toxic responses. , 1994, Reviews of physiology, biochemistry and pharmacology.

[70]  J. Lahtela,et al.  Enzyme Inducers Improve Insulin Sensitivity in Non-insulin-dependent Diabetic Subjects , 1985, Diabetes.

[71]  T. Kocarek,et al.  Regulation of sulfotransferases by xenobiotic receptors. , 2005, Current drug metabolism.

[72]  J. Stengård,et al.  Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus. , 1989, Diabetes research.

[73]  J. Chiang Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. , 2004, Journal of hepatology.

[74]  E. Schuetz,et al.  Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. , 2001, Molecular pharmacology.

[75]  T. Willson,et al.  The Nuclear Receptor CAR Is a Regulator of Thyroid Hormone Metabolism during Caloric Restriction* , 2004, Journal of Biological Chemistry.

[76]  J. S. Sidhu,et al.  Insulin‐mediated modulation of cytochrome P450 gene induction profiles in primary rat hepatocyte cultures , 1999, Journal of biochemical and molecular toxicology.

[77]  C. Klaassen,et al.  Effects of Microsomal Enzyme Inducers on Thyroid Follicular Cell Proliferation and Thyroid Hormone Metabolism , 2001, Toxicologic pathology.

[78]  J. Pascussi,et al.  Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. , 2000, Molecular pharmacology.

[79]  J. Goldstein,et al.  Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. , 2002, Molecular pharmacology.

[80]  K. Wikvall,et al.  6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. , 1999, Biochimica et biophysica acta.

[81]  T. Sueyoshi,et al.  Nuclear Pregnane X Receptor Cross-talk with FoxA2 to Mediate Drug-induced Regulation of Lipid Metabolism in Fasting Mouse Liver* , 2007, Journal of Biological Chemistry.

[82]  Hongbing Wang,et al.  A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression* , 2003, The Journal of Biological Chemistry.

[83]  D. DeFranco,et al.  Inhibition of Glucocorticoid Receptor Nucleocytoplasmic Shuttling by Okadaic Acid Requires Intact Cytoskeleton* , 1999, The Journal of Biological Chemistry.

[84]  C. Handschin,et al.  Cholesterol and Bile Acids Regulate Xenosensor Signaling in Drug-mediated Induction of Cytochromes P450* , 2002, The Journal of Biological Chemistry.

[85]  E. Morgan,et al.  Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase. , 2002, Biochemical pharmacology.

[86]  G. Perdew,et al.  Role of the aryl hydrocarbon receptor in drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.

[87]  Allan B. Okey,et al.  Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.

[88]  Paavo Honkakoski,et al.  The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene* , 1999, The Journal of Biological Chemistry.

[89]  J. Pascussi,et al.  Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. , 2000, Molecular pharmacology.

[90]  J. Brockmöller,et al.  Increase of cytochrome P450IA2 activity by omeprazole: Evidence by the 13C‐[N‐3‐methyl]‐caffeine breath test in poor and extensive metabolizers of S‐mephenytoin , 1992, Clinical pharmacology and therapeutics.

[91]  John T. Moore,et al.  CAR: detailing new models. , 2004, Trends in pharmacological sciences.

[92]  Jun Xia,et al.  Structural Determinants of Constitutive Androstane Receptor Required for Its Glucocorticoid Receptor Interacting Protein-1-mediated Nuclear Accumulation* , 2005, Journal of Biological Chemistry.

[93]  R. Evans,et al.  Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.

[94]  S. Bhatia,et al.  Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha. , 2005, Toxicology letters.

[95]  M. Ingelman-Sundberg,et al.  Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. , 2004, Molecular pharmacology.

[96]  D. Reinberg,et al.  Switching Partners in a Regulatory Tango , 2001, Science.

[97]  A. Fukamizu,et al.  Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. , 2003, Diabetes.

[98]  K. Guyton,et al.  Cancer chemoprevention using natural vitamin D and synthetic analogs. , 2003, Annual review of pharmacology and toxicology.

[99]  U. Meyer,et al.  Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. , 2004, Pharmacogenetics.

[100]  J. Peters,et al.  Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[101]  J. Pascussi,et al.  Transcriptional Regulation of CYP2C9 Gene , 2002, The Journal of Biological Chemistry.

[102]  M. Fromm,et al.  Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.

[103]  G. Caramori,et al.  Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids , 2001, Immunology and cell biology.

[104]  J. Pascussi,et al.  Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. , 2003, Molecular endocrinology.

[105]  V. Giguère,et al.  Orphan nuclear receptors: from gene to function. , 1999 .

[106]  J. Chiang,et al.  Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene. , 2003, Biochemical and biophysical research communications.

[107]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[108]  S. Kato The function of vitamin D receptor in vitamin D action. , 2000, Journal of biochemistry.

[109]  M. Gassmann,et al.  Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor , 1996, Molecular and cellular biology.

[110]  P. Harper,et al.  Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. , 2006, Biochemical pharmacology.

[111]  B. O’Malley,et al.  The Expanding Cosmos of Nuclear Receptor Coactivators , 2006, Cell.

[112]  R. Evans,et al.  Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[113]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[114]  P. Traber,et al.  Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract. , 1992, Gastroenterology.

[115]  Y. Fujii‐Kuriyama,et al.  Regulation of Dioxin Receptor Function by Omeprazole* , 1997, The Journal of Biological Chemistry.

[116]  B. Spiegelman,et al.  mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.

[117]  C. Handschin,et al.  Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. , 2005, Archives of biochemistry and biophysics.

[118]  A. Fukamizu,et al.  Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.

[119]  H. Hellmold,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. , 2005, Toxicology and applied pharmacology.

[120]  J. Lehmann,et al.  Orphan nuclear receptors: shifting endocrinology into reverse. , 1999, Science.

[121]  C. Glass Going nuclear in metabolic and cardiovascular disease. , 2006, The Journal of clinical investigation.

[122]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[123]  X. Leverve,et al.  Inhibition of gluconeogenesis in isolated rat hepatocytes after chronic treatment with phenobarbital. , 1991, The Biochemical journal.

[124]  J. Kemper,et al.  Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1α , 2004, Journal of Biological Chemistry.

[125]  J. Pascussi,et al.  Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[126]  E. Morgan Regulation of cytochromes P450 during inflammation and infection. , 1997, Drug metabolism reviews.

[127]  J. Pascussi,et al.  Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression. , 2007, Biochemical and biophysical research communications.

[128]  J. Pascussi,et al.  Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. , 2001, European journal of biochemistry.

[129]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[130]  J. Gustafsson What pharmacologists can learn from recent advances in estrogen signalling. , 2003, Trends in pharmacological sciences.

[131]  M. Stoffel,et al.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes , 2004, Nature.

[132]  R. Knutsen,et al.  Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice , 2003, Nature Medicine.

[133]  K. Wikvall,et al.  Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes. , 1999, Biochimica et biophysica acta.

[134]  B. Blumberg,et al.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.

[135]  J. Pascussi,et al.  Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. , 2000, Biochemical and biophysical research communications.

[136]  G. Perdew,et al.  Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. , 1999, The Journal of biological chemistry.

[137]  G. Semenza,et al.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.

[138]  A. Fukamizu,et al.  Inhibitory Effect of the Small Heterodimer Partner on Hepatocyte Nuclear Factor-4 Mediates Bile Acid-induced Repression of the Human Angiotensinogen Gene* , 2004, Journal of Biological Chemistry.

[139]  B. Viollet,et al.  Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver , 2006, Molecular Pharmacology.

[140]  S. Penzak,et al.  Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment. , 2000, Scandinavian journal of infectious diseases.

[141]  M. Castro‐Gago,et al.  Long‐Term Treatment of Children with Epilepsy with Valproate or Carbamazepine May Cause Subclinical Hypothyroidism , 1999, Epilepsia.

[142]  M. Gallo,et al.  Mechanism of Suppression of Cytochrome P-450 1A1 Expression by Tumor Necrosis Factor-α and Lipopolysaccharide* , 2001, The Journal of Biological Chemistry.

[143]  S. Kliewer,et al.  Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.

[144]  D. Waxman,et al.  Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR) , 2006, Drug metabolism reviews.

[145]  W. Sabbagh,et al.  SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.

[146]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[147]  M. E. Hahn,et al.  Aryl hydrocarbon receptors: diversity and evolution. , 2002, Chemico-biological interactions.

[148]  J. Auwerx,et al.  The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. , 2002, Molecular endocrinology.

[149]  Timothy M Willson,et al.  Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. , 2002, Molecular endocrinology.

[150]  L. Moore,et al.  Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes* , 2003, The Journal of Biological Chemistry.

[151]  Y Fujii-Kuriyama,et al.  Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. , 2005, Biochemical and biophysical research communications.

[152]  S. Eaton,et al.  Mammalian mitochondrial beta-oxidation. , 1996, The Biochemical journal.

[153]  N. Mitro,et al.  T0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR , 2007, FEBS letters.

[154]  F. Gonzalez,et al.  Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor γ1 (PPARγ1) Overexpression* , 2003, The Journal of Biological Chemistry.

[155]  J. Chiang,et al.  Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[156]  E. Kanaya,et al.  Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. , 2003, The Journal of biological chemistry.

[157]  F. Lasserre,et al.  The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity. , 2003, Molecular endocrinology.

[158]  B. Chatterjee,et al.  Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. , 2004, Molecular pharmacology.

[159]  R. Evans,et al.  A Novel Pregnane X Receptor-mediated and Sterol Regulatory Element-binding Protein-independent Lipogenic Pathway* , 2006, Journal of Biological Chemistry.

[160]  B. M. Forman,et al.  Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXR* , 2001, The Journal of Biological Chemistry.

[161]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[162]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[163]  D. Moore,et al.  Novel receptor interaction and repression domains in the orphan receptor SHP , 1997, Molecular and cellular biology.

[164]  P. Balaguer,et al.  Transcriptional Regulation of the Human NRIP1/RIP140 Gene by Estrogen Is Modulated by Dioxin Signalling , 2006, Molecular Pharmacology.

[165]  Ji Miao,et al.  Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1α* , 2006, Journal of Biological Chemistry.

[166]  T. Sueyoshi,et al.  Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. , 2001, Annual review of pharmacology and toxicology.

[167]  J. Reddy,et al.  Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. , 2003, The Journal of biological chemistry.

[168]  Stephen Safe,et al.  The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of Proteasomes , 2003, Molecular and Cellular Biology.

[169]  S. Safe,et al.  Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. , 2003, Chemical research in toxicology.

[170]  Christoph Handschin,et al.  Metabolic control through the PGC-1 family of transcription coactivators. , 2005, Cell metabolism.

[171]  P. Meier,et al.  Coordinate transcriptional regulation of transport and metabolism. , 2005, Methods in enzymology.

[172]  Y. Fujii‐Kuriyama,et al.  Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal‐induced interaction with CBP/p300 , 1999, The EMBO journal.

[173]  J. Kemper,et al.  Inhibitory Cross-talk between Estrogen Receptor (ER) and Constitutively Activated Androstane Receptor (CAR) , 2002, The Journal of Biological Chemistry.

[174]  P. Puigserver,et al.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[175]  J. Staudinger,et al.  The Ratio of Constitutive Androstane Receptor to Pregnane X Receptor Determines the Activity of Guggulsterone against the Cyp2b10 Promoter , 2005, Journal of Pharmacology and Experimental Therapeutics.

[176]  K. Matsui,et al.  The Nuclear Receptor Constitutively Active/Androstane Receptor Regulates Type 1 Deiodinase and Thyroid Hormone Activity in the Regenerating Mouse Liver , 2007, Journal of Pharmacology and Experimental Therapeutics.

[177]  C. Smith,et al.  Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X Receptor , 2006, Journal of Pharmacology and Experimental Therapeutics.

[178]  Sean Ekins,et al.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. , 2002, Pharmaceutical research.

[179]  L. Laffel Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.

[180]  Pascal G. P. Martin,et al.  Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. , 2005, The Journal of clinical investigation.

[181]  J. Pascussi,et al.  Interleukin 1β inhibits CAR‐induced expression of hepatic genes involved in drug and bilirubin clearance , 2004, Hepatology.

[182]  J. Sugatani,et al.  The phenobarbital response enhancer module in the human bilirubin UDP‐glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR , 2001, Hepatology.

[183]  S. Matern,et al.  Stimulation of bile acid 6 alpha-hydroxylation by rifampin. , 1996, Journal of hepatology.

[184]  S. Güngör,et al.  Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children. , 2001, Acta neurologica Belgica.

[185]  Tim Jordan,et al.  Fox's in development and disease. , 2003, Trends in genetics : TIG.

[186]  M. Norlin,et al.  Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia. , 2007, Biochemical and biophysical research communications.

[187]  D. Mangelsdorf,et al.  Pregnane X Receptor Is a Target of Farnesoid X Receptor* , 2006, Journal of Biological Chemistry.

[188]  F. Gonzalez,et al.  The Coactivator PGC-1 Is Involved in the Regulation of the Liver Carnitine Palmitoyltransferase I Gene Expression by cAMP in Combination with HNF4α and cAMP-response Element-binding Protein (CREB)* , 2002, The Journal of Biological Chemistry.

[189]  Oliver Burk,et al.  Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin* , 2001, The Journal of Biological Chemistry.

[190]  J. Pascussi,et al.  The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. , 2003, Biochimica et biophysica acta.

[191]  Kazumi Ito,et al.  Molecular mechanism investigation of phenobarbital-induced serum cholesterol elevation in rat livers by microarray analysis , 2004, Archives of Toxicology.